Our skin, like our gut, has its own microbiome. A microbiome is simply the collection of both good and bad bacteria in any given place. Many people take a daily pre/probiotic supplement and practice healthy eating habits to keep their gut microbiome in balance, so why are we not doing the same for the microbiome of our largest organ, our skin?
Our skin’s microbiome works hard to keep the skin in balance and to protect against infection, redness, inflammation, and other skin diseases. When the microbiome is thrown out of balance, we see various skin conditions arise such as atopic dermatitis 1, psoriasis 1, acne 2 or other more serious skin diseases 3. An unbalanced microbiome can also lead to a weaker barrier function, loss in hydration, dry, rough and fragile skin and an increase in the appearance of fine lines and wrinkles.
It’s helpful to understand what can cause these compromises in our skin, so let’s explore that a bit.
Our microbiome is under constant attack from a variety of factors – some avoidable and others not so much. Genetics, pollution, free-radical damage, lifestyle, diet, even pet dander can all play a part in disrupting our healthy bacteria. Any
time we subject our skin to injury or disruption of its natural state, we are also interfering with our microbiome.
Treating compromised skin requires a complex solution: We want to target the cause of the problem (an unbalanced microbiome) and we want to treat the symptoms (dry, irritated, weak, unhealthy skin). Vivier’s new and revolutionary product DERMA-V™ does both. With 5 key ingredients, DERMA-V™ offers a comprehensive solution for compromised skin. Here’s a look into this 5-in-1 reparative formula:
DERMA-V™ is the ideal product to use to enhance skin restoration – whether it’s an inherent issue like eczema, psoriasis, dryness or irritation or if you’re looking to restore and rebalance post-treatment or after years of using powerful active ingredients. DERMA-V™ will dramatically increase skin’s repair process to help reveal healthy, radiant, soothed skin. It’s also worth noting, DERMA-V™ can provide healing and comfort to skin that has been compromised due to side effects caused by oral medications, too. Some medications on the market, whether prescribed for skin conditions or otherwise, can cause dryness, flaking, cracking, and sensitivity in the skin. DERMA-V™ works as a solution to these skin issues.
DERMA-V™
REPAIR CREAM WITH PREBIOTICS AND ANTIOXIDANTS5 skin repairing ingredients to restore skin health while you sleep.
Try DERMA-V™ today for your healthiest, most protected and radiant skin.
Ideal for all skin types, including sensitive skin.
Until next time!
Stay safe, stay healthy.
By Claire Ashley
A Vivier Skin Care Expert.1. Zeeuwen PL, Klleerebezem M, Timmerman HM and Schalkwijk J. “Microbiome and Skin Diseases.” Curr Opin Allergy Immunol , October 13, 2013. https://www.ncbi.nlm.nih.gov/pubmed/23974680
2. Lee YB, Byun EJ and Kim HS. “Potential Role of the Microbiome in Acne: A Comprehensive Review.” J Clin Med, July 2019. https://www.ncbi.nlm.nih.gov/pubmed/31284694
3. Yu Y, Champer J, Beynet D, Kim J, Friedman AJ. “The Role of the Cutaneous Microbiome in Skin Cancer: Lessons Learned from the Gut.” J Drugs Dermatol, May 2015. https://www.ncbi.nlm.nih.gov/pubmed/25942663
4. Data on File
5. Al-Niami, F and Yi Zhen Chiang, N. “Topical Vitamin C and the Skin: Mechanisms of Action and Clinical Applications.” Journal of Clinical and Aesthetic Dermatology. July 2017. Volume 10. Number 7.
6. Michalun, M. Varinia, and Joseph C. DiNardo. Milady Skin Care and Cosmetic Ingredients Dictionary. 4th ed. Clifton Park, NY: Cengage Learning, 2015.
7. Papakonstantinou, Eleni, et al. “Hyaluronic Acid: A Key Molecule in Skin Aging.” Dermato-Endocrinology, Landes Bioscience, 1 July 2012, www.ncbi.nlm.nih.gov/pmc/articles/PMC3583886/
8. McKee CM, Lowenstein CJ, Horton MR, Wu J, Bao C, Chin BY, et al. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism. J Biol Chem 1997; 272:8013-8; PMID:9065473; http://dx.doi. org/10.1074/jbc.272.12.8013
9. Tytell M, Hooper PL. "Heat Shock Proteins: New Keys to the Development of Cytoprotective Therapies." April 2001. www.ncbi.nlm.nih.gov/pubmed/15992180
10. Data on File
